Berita Terbaru             -  Buletin Berita MESO Volume 37, No 1 Edisi Juni 2019            -  Buletin Berita MESO Volume 37, No 1 Edisi Juni 2019            -  INFORMASI LANJUTAN (FOLLOW UP COMMUNICATION) UNTUK TENAGA KESEHATAN PROFESIONAL TENTANG TINDAK LANJUT ANGIOTENSIN II RECEPTOR BLOCKER (ARB)            -  INFORMASI LANJUTAN (FOLLOW UP COMMUNICATION) UNTUK TENAGA KESEHATAN PROFESIONAL TENTANG TINDAK LANJUT ANGIOTENSIN II RECEPTOR BLOCKER (ARB)            -  INFORMASI LANJUTAN (FOLLOW UP COMMUNICATION) UNTUK TENAGA KESEHATAN PROFESIONAL TENTANG TINDAK LANJUT ANGIOTENSIN II RECEPTOR BLOCKER (ARB)

Event

Dear Colleagues,

 

We would like to inform you that Uppsala Monitoring Centre (UMC) and JSS University are pleased to announce their third Asia Pacific Pharmacovigilance Training Course, which will take place in Mysore, India from 16th to 27th January 2017.

 

The aim of the course is to develop pharmacovigilance knowledge and skills among health professionals in Asia Pacific region. The course focuses on topics essential to effective pharmacovigilance, including sessions to strengthen the overall WHO Programme, e.g. pharmacovigilance best practices, signal detection, regulatory aspects, reporting culture, benefit/harm assessment and pharmacovigilance tools.

 

The programme also includes a management component designed to help participants improve their capacity to influence sustainable change in their countries. Issues related to health economics, communications, fundraising and risk management are covered.

 

For more information please visit http://jsspharma.org/node/502

 

We hope this information will be useful for you.

Thank you for your attention.

 

Regards,

Administrator

National Center of Pharmacovigilance

NADFC - Indonesia

How do you think the content and appearance of this website?




logo dsras Email Rapid Alert System

Selamat email anda telah berlangganan untuk selalu mendapatkan informasi terkini mengenai keamanan obat yang beredar di Indonesia.

 

logo dsras Email Rapid Alert System

Anda ingin berhenti berlangganan untuk selalu mendapatkan informasi terkini mengenai keamanan obat yang beredar di Indonesia?